Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Xu

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Open Biology|August 10, 2022
A genetic model for <i>in vivo</i> proximity labelling of the mammalian secretomeRui Yang, Amanda S Meyer, Ilia A Droujinine, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 InhibitorsMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine|November 29, 2025
Targeting of HIF2-driven cachexia in kidney cancerMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine|January 28, 2026
Publisher Correction: argeting of HIF2-driven cachexia in kidney cancerMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Communications|April 3, 2023
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissuesJennifer G Abelin, Erik J Bergstrom, Keith D Rivera, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Open Biology|August 10, 2022
A genetic model for <i>in vivo</i> proximity labelling of the mammalian secretomeRui Yang, Amanda S Meyer, Ilia A Droujinine, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 InhibitorsMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine|November 29, 2025
Targeting of HIF2-driven cachexia in kidney cancerMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine|January 28, 2026
Publisher Correction: argeting of HIF2-driven cachexia in kidney cancerMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Communications|April 3, 2023
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissuesJennifer G Abelin, Erik J Bergstrom, Keith D Rivera, et al.
Pageof 7